Increased Antibiotic Susceptibility of Gram-Positive Bacteria in Cerebrospinal Fluid Compared to Broth

Jennifer S Wirth1,2, Marija Djukic1,2, Katrin Biesner1,2

  • 1Department of Geriatrics, Evangelisches Krankenhaus Göttingen-Weende, 37075 Göttingen, Germany.

PubMed

Insights

Antibiotic susceptibility testing in cerebrospinal fluid (CSF) reveals that standard broth methods often underestimate bacterial susceptibility. This finding is crucial for optimizing treatments against resistant Gram-positive bacteria in central nervous system infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Resistant Gram-positive bacteria pose a growing challenge for treating hospital- and community-acquired central nervous system (CNS) infections.
  • Current therapeutic strategies often struggle to identify effective antibiotic regimens for multi-drug resistant pathogens.
  • There is a need to improve methods for predicting in vivo efficacy despite reduced in vitro susceptibility.

Purpose of the Study:

  • To evaluate antibiotic susceptibility in cerebrospinal fluid (CSF) compared to standard culture media.
  • To determine if in vitro susceptibility testing in broth accurately reflects antibiotic effectiveness within the CNS environment.
  • To identify antibiotics that show improved efficacy in CSF compared to broth-based minimum inhibitory concentrations (MICs).

Main Methods:

  • Antibiotic susceptibility testing was performed on key pathogens including Enterococcus faecalis, methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, and Streptococcus pneumoniae.
  • Testing was conducted in both cerebrospinal fluid (CSF) and standard culture broths (Mueller-Hinton or Brain-Heart Infusion).
  • Minimal Inhibitory Concentrations (MICs) and Minimal Bactericidal Concentrations (MBCs) were determined for various antibiotics.

Main Results:

  • MICs and MBCs were found to be lower in CSF compared to broth for several antibiotic-pathogen combinations.
  • Significant differences were observed with gentamicin, levofloxacin, linezolid (against staphylococci), and vancomycin (against staphylococci and pneumococci).
  • In no instance were antibiotic concentrations higher in CSF than in broth, indicating broth MICs may underestimate in situ susceptibility.

Conclusions:

  • Standard broth-based MICs can underestimate the actual in situ susceptibility of bacteria within the CSF.
  • Several antibiotics demonstrate antibacterial activity in CSF at concentrations lower than those predicted by standard in vitro testing.
  • These findings suggest a need to reconsider standard susceptibility testing methods for CNS infections to optimize antibiotic selection.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial...
21